Designing drugs that overcome antibacterial resistance: Where do we stand and what should we do?

Expert Opinion on Drug Discovery

Volumn 10, Issue 6, 2015, Pages 631-650

  Penchovsky, Robert ^a   Traykovska, Martina ^a  

^a UNIVERSITY OF SOFIA   (Bulgaria)

Author keywords

Antibacterial drugs; Antimicrobial peptide; Antimicrobial resistance; Antisense oligonucleotides; Bacterial pathogens; Drug design; Phage therapy

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ENZYME; BACTERIAL RNA; DNA DIRECTED RNA POLYMERASE; POLYPEPTIDE ANTIBIOTIC AGENT; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL VIRULENCE; BACTERIOPHAGE; DRUG DESIGN; DRUG INHIBITION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SPECIFICITY; DRUG TARGETING; FLUORESCENCE; GASTROINTESTINAL TRACT; HIGH THROUGHPUT SCREENING; HUMAN; MICROBIAL COMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA TRANSCRIPTION; ANIMAL; BACTERIAL INFECTIONS; BACTERIUM; DRUG EFFECTS; HEALTH; MICROBIOLOGY; MULTIDRUG RESISTANCE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; DRUG DESIGN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GLOBAL HEALTH; HUMANS;

EID: 84929933183     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2015.1048219     Document Type: Review

References (73)

1. Theuretzbacher U, Toney JH. Natures clarion call of antibacterial resistance: are we listening? Curr Opin Investig Drugs 2006;7(2):158-66
2. Ling LL, Schneider T, Peoples AJ, et al. A new antibiotic kills pathogens without detectable resistance. Nature 2015;517(7535):455-9
3. Rosaschino F, Cattaneo L. Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL). Acta Biomed 2004;75(3):171-8
4. Barken KB, Haagensen JA, Tolker-Nielsen T. AdVances in nucleic acid-based diagnostics of bacterial infections. Clin Chim Acta 2007;384(1-2):1-11
5. Cottell JL, Saw HT, Webber MA, Piddock LJ. Functional genomics to identify the factors contributing to successful persistence and global spread of an antibiotic resistance plasmid. BMC Microbiol 2014;14:168
6. Kim DH, Choi JY, Kim HW, et al. Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands. Antimicrob Agents Chemother 2013;57(11):5239-46
7. Itokawa K, Komagata O, Kasai S, et al. Global spread and genetic variants of the two CYP9M10 haplotype forms associated with insecticide resistance in Culex quinquefasciatus Say. Heredity 2013;111(3):216-26
8. Johnson AP, Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 2013;62(Pt 4):499-513
9. Ndowa F, Lusti-Narasimhan M, Unemo M. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex Transm Infect 2012;88(5):317-18
10. Durante-Mangoni E, Zarrilli R. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol 2011;6(4):407-22
11. Yamane K, Wachino J, Doi Y, et al. Global spread of multiple aminoglycoside resistance genes. Emerg Infect Dis 2005;11(6):951-3
12. NIAID. NIAIDs antibacterial resistance program: current status and future directions. NIAID 2014;1(1):13
13. Hugh TB. Howard Florey, Alexander Fleming and the fairy tale of penicillin. Med J Aust 2002;177(1):2
14. Alanis AJ. Resistance to antibiotics: are we in the post-Antibiotic era? Arch Med Res 2005;36(6):697-705
15. Sutcliffe JA. Improving on nature: antibiotics that target the ribosome. Curr Opin Microbiol 2005;8(5):534-42
16. Levy SB, McMurry LM, Burdett V, et al. Nomenclature for tetracycline resistance determinants. Antimicrob Agents Chemother 1989;33(8):1373-4
17. Ban N, Nissen P, Hansen J, et al. The complete atomic structure of the large ribosomal subunit at 2.4 A resolution. Science 2000;289(5481):905-20
18. Cech TR. The ribosome is a ribozyme. Science 2000;289(5481):878-9
19. Wannigama DL, Dwivedi R, Zahraei-Ramazani A. Prevalence and antibiotic resistance of gram-negative pathogenic bacteria species isolated from Periplaneta americana and Blattella germanica in Varanasi, India. J Arthropod-Borne Dis 2014;8(1):10-20
20. Aksoy MD, Cavuslu S, Tugrul HM. Investigation of Metallo Beta Lactamases and Oxacilinases in Carbapenem Resistant Acinetobacter baumannii Strains Isolated from Inpatients. Balkan Med J 2015;32(1):79-83
21. Pray L. Antibiotic resistance, mutation rates and MRSA. Nat Educ 2008;1(1):30
22. Gustafsson I, Sjolund M, Torell E, et al. Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage. J Antimicrob Chemother 2003;52(4):645-50
23. Davies J. Origins and evolution of antibiotic resistance. Microbiologia 1996;12(1):9-16
24. Davies J, Davies D. Origins and evolution of antibiotic resistance. Microbiol Mol Biol Rev 2010;74(3):417-33
25. Crespi BJ. The evolution of social behavior in microorganisms. Trends Ecol Evol 2001;16(4):178-83
26. Lewis K. Platforms for antibiotic discovery. Nat Rev Drug Discov 2013;12(5):371-87
27. Keyser P, Elofsson M, Rosell S, Wolf-Watz H. Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gramnegative bacteria. J Intern Med 2008;264(1):17-29
28. Penchovsky R. Programmable and automated bead-based microfluidics for versatile DNA microarrays under isothermal conditions. Lab Chip 2013;13(12):10
29. Penchovsky R, McCaskill JS. Cascadable hybridisation transfer of specific DNA between microreactor selection modules. Lect Notes Comput Sci 2002;2340:10
30. Penchovsky R, Birch-Hirschfeld E, McCaskill JS. End-specific covalent photo-dependent immobilisation of synthetic DNA to paramagnetic beads. Nucleic Acids Res 2000;28(22):E98
31. Blount K, Puskarz I, Penchovsky R, Breaker R. Development and application of a high-throughput assay for glmS riboswitch activators. RNA Biol 2006;3(2):77-81
32. Blount KF, Breaker RR. Riboswitches as antibacterial drug targets. Nat Biotechnol 2006;24(12):1558-64
33. Penchovsky R, Breaker RR. Computational design and experimental validation of oligonucleotide-sensing allosteric ribozymes. Nat Biotechnol 2005;23(11):1424-33
34. Penchovsky R. Computational design and biosensor applications of small molecule-sensing allosteric ribozymes. Biomacromolecules 2013;14(4):1240-50
35. Penchovsky R. Present and future RNAbased approaches to medical genomics. Int J Genomic Med 2013;1(2):6
36. Penchovsky R. Nucleic Acids-based Nanotechnlogy: Engineering Principals and Applications. In: Bououdina M, Davim JP, editors, Handbook of research on nanoscience, nanotechnology, and adVanced materials. Engineering Science Reference (An Imprint of IGI Global); 2014:414-30
37. Penchovsky R. Computational design of allosteric ribozymes as molecular biosensors. Biotechnol Adv 2014;32(5):1015-27
38. Agresti JJ, Antipov E, Abate AR, et al. Ultrahigh-throughput screening in dropbased microfluidics for directed evolution. Proc Natl Acad Sci USA 2010;107(9):4004-9
39. Schonbrun E, Abate AR, Steinvurzel PE, et al. High-throughput fluorescence detection using an integrated zone-plate array. Lab Chip 2010;10(7):852-6
40. Manganelli G, Masullo U, Filosa S. HTS/HCS to screen molecules able to maintain embryonic stem cell selfrenewal or to induce differentiation: overview of protocols. Stem Cell Rev 2014;10(6):802-19
41. Azegrouz H, Karemore G, Torres A, et al. Cell-based fuzzy metrics enhance high-content screening (HCS) assay robustness. J Biomol Screen 2013;18(10):1270-83
42. Bai H, Xue X, Hou Z, et al. Antisense antibiotics: a brief review of novel target discovery and delivery. Curr Drug Discov Technol 2010;7(2):76-85
43. Winkler WC, Cohen-Chalamish S, Breaker RR. An mRNA structure that controls gene expression by binding FMN. Proc Natl Acad Sci USA 2002;99(25):15908-13
44. Lee ER, Blount KF, Breaker RR. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA Biol 2009;6(2):187-94
45. Penchovsky R, Stoilova CC. Riboswitch-based antibacterial drug discovery using high-throughput screening methods. Expert Opin Drug Discov 2013;8(1):65-82
46. Chan JH, Lim S, Wong WS. Antisense oligonucleotides: from design to therapeutic application. Clin Exp Pharmacol Physiol 2006;33(5-6):533-40
47. Dryselius R, Nekhotiaeva N, Nielsen PE, Good L. Antibiotic-free bacterial strain selection using antisense peptide nucleic acid. Biotechniques 2003;35(5):1060-4
48. Ray A, Norden B. Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future. FASEB J 2000;14(9):1041-60
49. Stock RP, Olvera A, Scarfi S, et al. Inhibition of neomycin phosphorotransferase expression in Entamoeba histolytica with antisense peptide nucleic acid (PNA) oligomers. Arch Med Res 2000;31(4 Suppl):S271-2
50. Shiraishi T, Nielsen PE. Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers. Artif DNA PNA XNA 2011;2(3):90-9
51. Fillion P, Desjardins A, Sayasith K, Lagace J. Encapsulation of DNA in negatively charged liposomes and inhibition of bacterial gene expression with fluid liposome-encapsulated antisense oligonucleotides. Biochim Biophys Acta 2001;1515(1):44-54
52. Moulton HM. Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers. Methods Mol Biol 2012;867:407-14
53. Qadir MI. Review: Phage therapy: A modern tool to control bacterial infections. Pak J Pharm Sci 2015;28(1):265-70
54. Loc-Carrillo C, Abedon ST. Pros and cons of phage therapy. Bacteriophage 2011;1(2):111-14
55. Agne M, Blank I, Emhardt AJ, et al. Modularized CRISPR/dCas9 effector toolkit for target-specific gene regulation. ACS Synth Biol 2014;3(12):986-9
56. Barrangou R, May AP. Unraveling the potential of CRISPR-Cas9 for gene therapy. Expert Opin Biol Ther 2014;1-4
57. Gilgenkrantz H. [The revolution of the CRISPR is underway]. Med Sci 2014;30(12):1066-9
58. Fairhead H. SASP gene delivery: a novel antibacterial approach. Drug News Perspect 2009;22(4):197-203
59. Gaspar D, Veiga AS, Castanho MA. From antimicrobial to anticancer peptides. A review. Front Microbiol 2013;4:294
60. Aoki W, Ueda M. Characterization of antimicrobial peptides toward the development of novel antibiotics. Pharmaceuticals 2013;6(8):1055-81
61. Bahar AA, Ren D. Antimicrobial peptides. Pharmaceuticals 2013;6(12):1543-75
62. Seo MD, Won HS, Kim JH, et al. Antimicrobial peptides for therapeutic applications: a review. Molecules 2012;17(10):12276-86
63. Diamond G, Beckloff N, Weinberg A, Kisich KO. The roles of antimicrobial peptides in innate host defense. Curr Pharm Des 2009;15(21):2377-92
64. Potashman MH, Formella DN, Hamed K, Mohr JF. Comment on: Efficacy and safety of daptomycin for the treatment of infectious disease: a metaanalysis based on randomized controlled trials. J Antimicrob Chemother 2014;69(12):3181-89
65. McElVania TeKippe E, Thomas BS, Ewald GA, et al. Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum cautionary tale. Eur J Clin Microbiol Infect Dis 2014;33(12):2199-205
66. Kai-Larsen Y, Gudmundsson GH, Agerberth B. A review of the innate immune defence of the human foetus and newborn, with the emphasis on antimicrobial peptides. Acta Paediatr 2014;103(10):1000-8
67. Dean SN, Bishop BM, Van Hoek ML. Natural and synthetic cathelicidin peptides with anti-microbial and antibiofilm activity against Staphylococcus aureus. BMC Microbiol 2011;11:114
68. Lee DK, Park JE, Kim MJ, et al. Probiotic bacteria, B. longum and L. acidophilus inhibit infection by rotavirus in vitro and decrease the duration of diarrhea in pediatric patients. Clin Res Hepatol Gastroenterol 2015;39(2):237-44
69. Kelly CP. Fecal microbiota transplantation-An old therapy comes of age. N Engl J Med 2013;368(5):474-5
70. Marianelli C, Cifani N, Pasquali P. Evaluation of antimicrobial activity of probiotic bacteria against Salmonella enterica subsp. enterica serovar typhimurium 1344 in a common medium under different environmental conditions. Res Microbiol 2010;161(8):673-80
71. Kizerwetter-Swida M, Binek M. Selection of potentially probiotic Lactobacillus strains towards their inhibitory activity against poultry enteropathogenic bacteria. Pol J Microbiol 2005;54(4):287-94
72. Kirst HA. Developing new antibacterials through natural product research. Expert Opin Drug Discov 2013;8(5):14
73. Foster KR. Social behaviour in microorganisms. Soc Behav 2010;1(1):39